Related content

Randomized conversion from cyclosporine to tacrolimus in renal transplant patients: improved lipid profile and unchanged plasma homocysteine levels

By Artz M.A.   Boots J.M.M.   Ligtenberg G.   Roodnat J.I.   Christiaans M.H.L.   Hene R.J.   Blom H.J.   Demacker P.N.M.   Hilbrands L.B.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1793-1794

Elsevier

Access to resources Recommend Favorite

Influence of anticalcineurinic therapy in plasma homocysteine levels of renal transplant recipients: a prospective study

By Laures A.S.   Gomez E.   Alvarez V.   Coto E.   Baltar J.   Alvarez-Grande J.  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1739-1741

Elsevier

Access to resources Recommend Favorite

Lower Fasting Total Plasma Homocysteine Levels in Stable Renal Transplant Recipients Versus Maintenance Dialysis Patients

By Bostom A.G.   Shemin D.   Gohh R.Y.   Verhoef P.   Nadeau M.R.   Bianchi L.A.   Hopkins-Garcia B.J.   Jacques P.F.   Selhub J.   Dworkin L.   Rosenberg I.H.  

Transplantation Proceedings, Vol. 30, Iss. 1, 1998-02 ,pp. : 160-162

Elsevier

Access to resources Recommend Favorite

Steroid withdrawal from tacrolimus-based therapy in renal transplant patients

By Citterio F.   Rigotti P.   Scata M.C.   Romagnoli J.   Baldan N.   Marchini F.   Castagneto M.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1707-1708

Elsevier

Access to resources Recommend Favorite

Levels of mycophenolic acid and its glucuronide derivative in the plasma of liver, small bowel and kidney transplant patients receiving tacrolimus and cellcept combination therapy

By Tsaroucha A.K.   Zucker K.   Esquenazi V.   de Faria L.   Miller J.   Tzakis A.G.  

Transplant Immunology, Vol. 8, Iss. 2, 2000-06 ,pp. : 143-146

Elsevier

Access to resources Recommend Favorite